Health Care

Horizon Pharma plc (NASDAQ:HZNP) expecting to hit $30.46 Price Target

0 33

Shares of Horizon Pharma plc (NASDAQ:HZNP) declined -0.39% and ended at $17.83 smaller than previous closing price of $17.90. The total 3.45 million shares were bought and sold throughout the most recent trading session less than average volume of 4.14 million shares.

Horizon Pharma plc (HZNP):

Currently Horizon Pharma plc (HZNP) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “11″ Analysts”. “0” rated “Sell” for the company. “2” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $30.46 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $45.00 however minimum price target advised by analysts is $21.00. The Median price target for the stock is measured at $30.00.

Presently, Analysts decided consensus EPS estimate of $0.63 for present quarter and one month ago projected EPS estimate was at $0.69. If we take a look at back 3 month ago, consensus EPS estimate was $0.69.

A current consensus EPS estimate for next quarter is at $0.71 and 3 month ago EPS forecast was $0.80. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.81.

For current fiscal year, most recent EPS estimate is set at $2.21 based on Analyst consensus and three month ago consensus EPS opinions was at $2.34. During period one month ago, consensus EPS forecast was decided at $2.38.

A current consensus EPS projection for next fiscal year is observed at $2.58 and one month ago consensus EPS forecast was at $2.68. Take a look at back three month ago, consensus EPS estimate opinions was decided at $2.65 by analysts.

One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 11 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 2 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 10 said a “Buy Rating” and 0 announced “Overweight Rating”. 1 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.


About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.